Why Nebius Shares Are Falling Despite Strong Wall Street Backing
New York, Tuesday, 13 October 2026.
Nebius Group shares dropped 5% despite a new Wall Street Buy rating, driven by broader AI valuation concerns, disappointing industry revenue reports, and recent insider share sales.
Market Reaction to Rosenblatt Initiation
Shares of Nebius Group N.V. (NASDAQ: NBIS) experienced a significant decline on Monday, 12 October 2026, closing at USD 210.06 following a drop of USD 11.01, representing a 4.98% decrease [7]. This downward movement occurred despite Rosenblatt Securities initiating coverage with a Buy rating and a price target of USD 304 earlier in the week [2]. The stock had previously traded at USD 214.99 on 12 October 2026, reflecting a 3% drop during that specific session [1]. Market data indicates the stock touched a session low of USD 209.19 during morning trading as selling pressure intensified [3].
Sector-Wide Volatility and Insider Activity
The pullback in Nebius shares coincided with broader softness among specialized AI cloud infrastructure vendors, including CoreWeave, highlighting short-term volatility in the high-flying AI compute sector [1]. Concerns were compounded by reports that OpenAI’s annualized revenue had come in below earlier market expectations, rattling investor confidence across the neocloud sector [3]. Additionally, a wave of significant insider selling surfaced in early October, including the company’s COO disposing of a large block of shares and the CTO liquidating a portion of his holdings [3]. These transactions were conducted through preset trading plans but contributed to a lingering cloud over sentiment [5].
Financial Metrics and Valuation Context
As of 12 October 2026, Nebius Group NV held a market capitalization of USD 57.11 billion with a price-to-earnings ratio of 794.48x [4]. The company’s 52-week price range sits between USD 73.52 and USD 299.86, indicating substantial recent volatility [4]. In terms of operational performance, Nebius reported Q2 2026 revenue of USD 582.3 million, representing a 454% increase, alongside an adjusted EBITDA of USD 236.2 million [2]. The stock still trades at a substantial premium to revenue despite pulling back significantly from its 52-week high [3].
Analyst Consensus and Future Outlook
While Rosenblatt set a price target of USD 304, the consensus among analysts lies at a Moderate Buy rating with an average price target of USD 245.69 [6]. The potential upside from the closing price of USD 210.06 to the Rosenblatt target represents a difference of 93.94 per share [2][7]. Investors are currently awaiting the next earnings report scheduled for 10 November 2026, with an estimated earnings per share of negative USD 1.10 [4]. Broader market conditions offer little relief for high-beta growth names, with the Nasdaq modestly lower while the S&P 500 remains essentially flat [3].
Sources
- finance.yahoo.com
- stocktwits.com
- www.investing.com
- public.com
- www.streetinsider.com
- www.wallstreet-online.de
- finance.yahoo.com
- www.tikr.com